For patients with acute myeloid leukemia (AML) receiving intensive chemotherapy, AML-SCORE and PINA-Score help to estimate 1) complete remission and early death rate in patients ≥60 years and 2) probabilities of overall and relapse-free survival in patients with AML with normal karyotype.
SAL Study Alliance Leukemia

Frequently asked questions

Questions on the registration procedure

I filled in the form, but I can not log in?
After filling the form you will receive an e-mail. You have to click the link in the e-mail to activate your account.

I did not receive an e-mail
Please check out your spam-folder. Are you sure you filled in the correct e-mail-address?

I need help!
Please write to admin[at]


Questions on AML-Score

Please write an e-mail to info[at]

Questions on PINA-Score

Please write an e-mail to PINA[at]